CMS Open Payments · Program Year 2024
Mf Med
Mf Med reported $630.54 across General Payments, Research, and Ownership to 18 physicians and teaching hospitals across 18 transactions.
- $630.54
- All-tracks total
- 18
- Transactions
- 18
- Recipients
- #1867
- of 1,925 companies
Mf Med reported $630.54 across all CMS Open Payments tracks (General + Research + Ownership) to 18 physicians and teaching hospitals in Program Year 2024 - ranking #1867 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $630.54, averaging $35.03 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer mf-med Mf Med
$630.54 · #1867/1,925 · 0.0% industry · PY2024
- TOT $630.54
- RANK #1867
- SHARE 0.0%
- TXN 18
- RCP 18
- CAT 1
- GEN $630.54
- TOP1 20.9%
- PY 2024
Volume peers
Nearest volume peer: Avirmax Biopharma, Inc ($631.49)
Mf Med sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Mf Med
Rank #1867 of 1,925 companies in CMS Open Payments for 2024 belongs to Mf Med, which reported $630.54 across 18 transactions to 18 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $35.03 per transaction and $35.03 per recipient.
"Food and Beverage" leads the 1-category general-payment breakdown below at $630.54 (100.0% of General Payments, 18 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Mf Med made 1 types of general payments. "Food and Beverage" is the largest category at $630.54, 100.0% of General Payments.
How Mf Med divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $630.54 | 18 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $387.45 (61.4%) of $630.54 in this company's General Payments records across 18 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Mf Med
The five named recipients with the highest reported General Payments from this company
- 1
Charles Cossell
$131.65 across 1 reported transactions
- 2
Brandon Horn
$83.95 across 1 reported transactions
- 3
Stephen Shively
$64.95 across 1 reported transactions
- 4
Eric Tannenbaum
$55.00 across 1 reported transactions
- 5
Ganeshan Ramachandran
$51.90 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Mf Med's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Mf Med.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Mf Med.
Showing 6 of 1,924 companies with CMS-reported payment data.
aap Implants Inc
Nurami Medical Ltd
curasan, Inc.
Cook Biotech Incorporated
Pixee Medical Inc.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.